Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
4.0
3.8
Journals
Bioengineering
Special Issues
10th Anniversary of Bioengineering: Perspectives in Bioengineering
share announcement

10th Anniversary of Bioengineering: Perspectives in Bioengineering

A special issue of Bioengineering (ISSN 2306-5354).

Deadline for manuscript submissions: 31 December 2024 | Viewed by 7872

Special Issue Editors

Prof. Dr. Anthony Guiseppi-Elie

E-Mail Website1 Website2
Guest Editor
Department of Biomedical Engineering, Texas A&M University, College Station, TX 77843, USA
Interests: biomolecular engineering; biochip implant biocompatibility; in vivo biosensors; cell-based sensing; electronic nose; brain tumor biochip; bioelectronic devices and bioelectrochemistry
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Gary L. Bowlin

E-Mail Website
Guest Editor
Department of Biomedical Engineering, The University of Memphis, 119D Engineering Technology, Memphis, TN 38152, USA
Interests: tissue engineering; electrospinning; scaffolds; vascular tissue engineering; bone tissue engineering; in situ regeneration, angiogenesis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

As Bioengineering celebrates its 10th anniversary, we are looking to highlight and celebrate the success of select bioengineering-focused centers around the world. You are invited to contribute 10,000 words and 5 figures that serve to highlight the major transformative accomplishments (research-to-innovation, bench-to-bedside, fab-to-factory, or innovations that are clearly on a path to doing so) contributed by your center over the last 10 years. Of equal importance and high relevance are contributions to new scientific directions, new methods, and/or new tools that have changed the course of inquiry or are poised to do so. This special 10th Anniversary Commemorative Issue will curate the major accomplishments of a selected number of high-impact centers from around the world. 

The deadline is April 15th, 2024.

APC: 100% discount of CHF 2700 (Swiss Francs) = CHF 0.00 (Invited contributors only)

Bioengineering (ISSN 2306-5354), under its Founding Editor-in-Chief, Prof. Dr. Anthony Guiseppi-Elie, is an open access journal that provides a forum for advances in the science and technology of biological and biomedical engineering and is published monthly online by MDPI. Launched in 2014, Bioengineering will celebrate its 10-year anniversary in 2024 with a Special Commemorative Issue: “Perspectives in Bioengineering”. You are invited to contribute your perspective in this Commemorative Issue.

Perspectives may originate from the vantage point of the several main sections of the journal:

  • Biomedical Biomaterials (SEiC, Prof. Gary Bowlin, University of Memphis, USA);
  • Biomechanics and Sports Medicine (SEiC, Dr. Franz Konstantin Fuss, University of Bayreuth, Germany);
  • Regenerative and Tissue Engineering (SEiC, Elena A. Jones, University of Leeds, UK);
  • Nano-Biotechnology (SEiC, Dr. Gary Chinga Carrasco, RISE PFI, Norway);
  • Biosignal Processing (SEiC,  Andrea Cataldo University of Salento, Italy);
  • Biochemical Engineering (SEiC, Prof. Dr. Liang Luo, Huazhong University of Science and Technology, China. 

Bioengineering has a reputable Editorial Board comprising well-established researchers such as Prof. Dr. Anthony Atala, Prof. Dr. Eben Alsberg, Prof. Dr. Ali Khademhosseini, Prof. Dr. Dietmar W. Hutmacher, Prof. Dr. Fergal J. O'Brien, Prof. Dr. Jason A. Burdick, Prof. Dr. Aldo R. Boccaccini, Prof. Dr. Gary S. Stein, and Prof. Dr. Daniel G. Anderson and is indexed by some leading archival indexing services, including SCIE (IF 4.6), Scopus (CiteScore of 4.2, which equals rank 34/96 (Q2)), PubMed, Web of Science BIOSIS, and INSPEC (IET).

We also welcome any inquiries regarding the form and format of your contribution. We have established 10,000 words and 5 figures as a general guide. However, we can be flexible so that you can tell your impact story as desired.

Prof. Dr. Anthony Guiseppi-Elie
Prof. Dr. Gary L. Bowlin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bioengineering
  • biomedical biomaterials
  • sport biomechanics
  • regenerative and tissue engineering
  • nano-biotechnology
  • biosignal processing
  • biochemical engineering

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (5 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Editorial

Jump to: Review, Other

8 pages, 1812 KiB  
Editorial
Commemorative 10th Anniversary Issue of Bioengineering: Perspectives in Bioengineering
by Anthony Guiseppi-Elie
Bioengineering 2024, 11(11), 1137; https://doi.org/10.3390/bioengineering11111137 - 12 Nov 2024
Viewed by 724
Abstract
In 2014, as the Founding Editor-in-Chief, I welcomed you to the first issue of a new open access MDPI journal, Bioengineering [...] Full article
(This article belongs to the Special Issue 10th Anniversary of Bioengineering: Perspectives in Bioengineering)
►▼ Show Figures

Figure 1

Review

Jump to: Editorial, Other

14 pages, 3454 KiB  
Review
Driving Deployment of Bioengineered Products—An Arduous, Sometimes Tedious, Challenging, Rewarding, Most Exciting Journey That Has to Be Made!
by Gordon George Wallace
Bioengineering 2024, 11(8), 856; https://doi.org/10.3390/bioengineering11080856 - 22 Aug 2024
Cited by 1 | Viewed by 895
Abstract
More than three decades ago, we embarked on a number of bioengineering explorations using the most advanced materials and fabrication methods. In every area we ventured into, it was our intention to ensure fundamental discoveries were deployed into the clinic to benefit patients. [...] Read more.
More than three decades ago, we embarked on a number of bioengineering explorations using the most advanced materials and fabrication methods. In every area we ventured into, it was our intention to ensure fundamental discoveries were deployed into the clinic to benefit patients. When we embarked on this journey, we did so without a road map, not even a compass, and so the path was arduous, sometimes tedious. Now, we can see the doorway to deployment on the near horizon. We now appreciate that overcoming the challenges has made this a rewarding and exciting journey. However, maybe we could have been here a lot sooner, and so maybe the lessons we have learned could benefit others and accelerate progress in clinical translation. Through a number of case studies, including neural regeneration, cartilage regeneration, skin regeneration, the 3D printing of capsules for islet cell transplantation, and the bioengineered cornea, here, we retrace our steps. We will summarise the journey to date, point out the obstacles encountered, and celebrate the translational impact. Then, we will provide a framework for project design with the clinical deployment of bioengineered products as the goal. Full article
(This article belongs to the Special Issue 10th Anniversary of Bioengineering: Perspectives in Bioengineering)
►▼ Show Figures

Figure 1

16 pages, 3954 KiB  
Review
Supercritical Fluids: An Innovative Strategy for Drug Development
by Hui Liu, Xiaoliu Liang, Yisheng Peng, Gang Liu and Hongwei Cheng
Bioengineering 2024, 11(8), 788; https://doi.org/10.3390/bioengineering11080788 - 4 Aug 2024
Cited by 1 | Viewed by 2130
Abstract
Nanotechnology plays a pivotal role in the biomedical field, especially in the synthesis and regulation of drug particle size. Reducing drug particles to the micron or nanometer scale can enhance bioavailability. Supercritical fluid technology, as a green drug development strategy, is expected to [...] Read more.
Nanotechnology plays a pivotal role in the biomedical field, especially in the synthesis and regulation of drug particle size. Reducing drug particles to the micron or nanometer scale can enhance bioavailability. Supercritical fluid technology, as a green drug development strategy, is expected to resolve the challenges of thermal degradation, uneven particle size, and organic solvent residue faced by traditional methods such as milling and crystallization. This paper provides an insight into the application of super-stable homogeneous intermix formulating technology (SHIFT) and super-table pure-nanomedicine formulation technology (SPFT) developed based on supercritical fluids for drug dispersion and micronization. These technologies significantly enhance the solubility and permeability of hydrophobic drugs by controlling the particle size and morphology, and the modified drugs show excellent therapeutic efficacy in the treatment of hepatocellular carcinoma, pathological scarring, and corneal neovascularization, and their performance and efficacy are highlighted when administered through multiple routes of administration. Overall, supercritical fluids have opened a green and efficient pathway for clinical drug development, which is expected to reduce side effects and enhance therapeutic efficacy. Full article
(This article belongs to the Special Issue 10th Anniversary of Bioengineering: Perspectives in Bioengineering)
►▼ Show Figures

Figure 1

20 pages, 7694 KiB  
Review
Bio-Hybrid Magnetic Robots: From Bioengineering to Targeted Therapy
by Qian Zhang, Yun Zeng, Yang Zhao, Xuqi Peng, En Ren and Gang Liu
Bioengineering 2024, 11(4), 311; https://doi.org/10.3390/bioengineering11040311 - 26 Mar 2024
Cited by 3 | Viewed by 2739
Abstract
Magnetic robots possess an innate ability to navigate through hard-to-reach cavities in the human body, making them promising tools for diagnosing and treating diseases minimally invasively. Despite significant advances, the development of robots with desirable locomotion and full biocompatibility under harsh physiological conditions [...] Read more.
Magnetic robots possess an innate ability to navigate through hard-to-reach cavities in the human body, making them promising tools for diagnosing and treating diseases minimally invasively. Despite significant advances, the development of robots with desirable locomotion and full biocompatibility under harsh physiological conditions remains challenging, which put forward new requirements for magnetic robots’ design and material synthesis. Compared to robots that are synthesized with inorganic materials, natural organisms like cells, bacteria or other microalgae exhibit ideal properties for in vivo applications, such as biocompatibility, deformability, auto-fluorescence, and self-propulsion, as well as easy for functional therapeutics engineering. In the process, these organisms can provide autonomous propulsion in biological fluids or external magnetic fields, while retaining their functionalities with integrating artificial robots, thus aiding targeted therapeutic delivery. This kind of robotics is named bio-hybrid magnetic robotics, and in this mini-review, recent progress including their design, engineering and potential for therapeutics delivery will be discussed. Additionally, the historical context and prominent examples will be introduced, and the complexities, potential pitfalls, and opportunities associated with bio-hybrid magnetic robotics will be discussed. Full article
(This article belongs to the Special Issue 10th Anniversary of Bioengineering: Perspectives in Bioengineering)
►▼ Show Figures

Figure 1

Other

Jump to: Editorial, Review

14 pages, 4068 KiB  
Perspective
The Origins of Engineered Biomaterials: NSF-Funded, University of Washington Engineered Biomaterials (UWEB)
by Buddy D. Ratner
Bioengineering 2024, 11(11), 1117; https://doi.org/10.3390/bioengineering11111117 - 6 Nov 2024
Cited by 1 | Viewed by 660
Abstract
The University of Washington Engineered Biomaterials (UWEB) Engineering Research Center (ERC) was funded from 1996 to 2007 by the U.S. National Science Foundation. The mission of UWEB was to advance biomaterials by integrating modern biology with materials science. UWEB specifically focused on the [...] Read more.
The University of Washington Engineered Biomaterials (UWEB) Engineering Research Center (ERC) was funded from 1996 to 2007 by the U.S. National Science Foundation. The mission of UWEB was to advance biomaterials by integrating modern biology with materials science. UWEB specifically focused on the healing and integration of medical implants. UWEB teamed biologists, physicians, engineers, and industry and demonstrated three paths that might advance biomaterials so they could seamlessly integrate and heal in the body. The three primary lines of investigation were precision porous scaffolds, super-non-fouling surfaces, and the control of matricellular proteins. The UWEB program set the groundwork for the modern field of immunoengineering. Also, UWEB invested significantly in training scientists/engineers who could freely integrate advances in biological sciences, state-of-the-art materials science, and medical technology. This historical summary of the UWEB program demonstrates that federal investment in interfacing forefront fields can yield dividends with benefits for society and the economy. Full article
(This article belongs to the Special Issue 10th Anniversary of Bioengineering: Perspectives in Bioengineering)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-5
Back to TopTop